- Home
- MANE vs STAA Comparison
MANE vs STAA Comparison
Compare MANE & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MANE | STAA |
|---|---|---|
| Founded | 2019 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | MANE | STAA |
|---|---|---|
| Price | $91.82 | $29.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $83.33 | $22.81 |
| AVG Volume (30 Days) | 409.9K | ★ 640.9K |
| Earning Date | 03-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | N/A | $30.82 |
| Revenue Next Year | N/A | $8.41 |
| P/E Ratio | ★ N/A | $288.85 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $36.26 | $15.59 |
| 52 Week High | $117.71 | $35.87 |
Technical Indicators
Market Signals| Indicator | MANE | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 47.95 | 50.23 |
| Support Level | $92.94 | $28.03 |
| Resistance Level | $107.95 | $31.05 |
| Average True Range (ATR) | 6.50 | 1.00 |
| MACD | -1.04 | -0.28 |
| Stochastic Oscillator | 38.75 | 36.09 |
Price Performance
Historical ComparisonAbout MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.